Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

Tecan Journal dot

Selected category: Biopharma & Drug Discovery

Back to overview

Designer chemotherapy

Brain tumors are the most common cause of mortality in childhood cancer patients, and treatment options are limited, especially for recurrent cases. Researchers at the University Hospital Düsseldorf are using automation to develop a more personalized approach to cancer medicine, performing rapid drug screening to identify novel therapeutic strategies to improve the chances of survival.

Read more

Perfecting technology for the NIH Roadmap

Scientists at Columbia University have created three flexible, fully automated workstations based on Freedom EVO® 200 platforms for the assay development work they are performing as part of the NIH Molecular Libraries Roadmap initiative.

Read more
empty cart | close cart
Your cart

Your cart is empty.

Get a quote close form